Immune checkpoint molecules (such as PDCD1, CD274, and CTLA4) and co-stimulatory molecules were also highly expressed in low-risk melanoma group (FDR-adjusted P < 0.05, one-sided Wilcoxon rank-sum test, Fig. 5h, i). Here, CTLA4 is linked to melanoma.